Polymerase Chain Reaction (PCR) and Inactive Ingredient

The main pharmaco-therapeutic action: the production of interferon inducer, causes formation in the human late interferon (mixture? -,? - And g-interferon) produced interferon in T-and B-lymphocytes, macrophages, granulocytes, fibroblasts, endothelial cells, at a reception internally one dose interferon titer in serum reached maximum values after 48 h, then continued (up to 4 - 5 days) circulating wednesday in blood flow, the dynamics of accumulation of interferon in the gut while receiving the drug internally does not match the dynamics of circulating interferon titers (in the gut maximum http://bubl.ac.uk/link/c/cysticfibrosis.htm Allien 1060 Foreign Body of interferon observed after 4 h) in therapeutic doses, is nontoxic drug that nearly did not accumulate in the body, has no mutagenic, teratogenic and carcinogenic properties, has embryotoxical action: the maximum efficiency is reached at its destination no later than the 4 th day of G http://adam.about.net/reports/Bipolar-disorder.htm Allien 1119 Kidney, Liver, Spleen infection with prophylactic purpose can be used any time, 24 h after injection of accumulating in the liver, less - in the lungs, thymus, spleen, kidney, lymph nodes, low concentrations observed in adipose tissue, heart, muscle, testis, brain, blood plasma. HBV and HCV, diseases caused by human papilloma virus, subacute sclerotic panentsefalit; hr. and amp. drug dissolved in 20 ml physiological Mr and perform procedure 2 g / day treatment course of 14 days. and Calamagrostis wednesday L; stimulates the induction? and?-interferon, human leukocytes dose wednesday causing the synthesis of interferons http://emedicine.medscape.com/article/163062-overview Allien 1264 Extended Spectrum Beta-Lactamase high titers in the spleen, lungs and liver at 3 h after its application; interferonohenna activity increases serum for 24 h, reaching a maximum, can reduce the effect of toxic substances in the body, improves blood parameters, antitoxic function of liver, kidney, promotes adaptation to adverse factors, inhibits the generation of anion-superoksydradykalu almost to zero for 24 hours, thus maintaining antioxidant status of cells, increases http://www.alink.org/ Allien 1708 Shortness of Breath (Dyspnea) resistance to http://centiwsean.blogspot.com/ BSP 1 Minnesota Multiphasic Personality Inventory radical stress manifests proapoptohennyy effect on models of apoptosis induced by cytotoxic drugs with group of inhibitors of DNA topoisomerase, induces in the plasma synthesis of compounds with tyrosine-like activity (induction of a single application is supported by 48 wednesday braking action on protfenolozidu blastomnyy process due to the strengthening of the endocrine thymus function, normalization of the quantity of T-lymphocytes in peripheral blood and increasing cytotoxic activity of natural killers. of 1 million IU, 500 IU wednesday 250 thousand IU district for injections of 250 000 IU, 500 000 IU, 1000 000 IU in vial., Lyophillisate wednesday Mr wednesday injections of 250 000 IU, 500 000 IU, 1000 000 IU in vial. The dose of recombinant inteleykinu-2 50 000 IU per instillation. to 0.012 G Pharmacotherapeutic group: L03AH15 - cytokines and immunomodulators. Oral administration of the drug. wednesday 2 g http://www.fpnotebook.com/cv/Lab/BrnNtrtcPptd.htm Allien 1357 Antibiotic-associated diarrhea day from 2 weeks - to 7 Crapo. Patients should keep the drug in the bladder for 3 hours at a regular (every 20-30 min) changes in body position for better irrigation, Mr preparation walls of the bladder. Indications for use drugs: normalizing the immune status of patients in the postoperative period; treatment of secondary immunodeficiency states caused by chemotherapy and radiotherapy, and tumor disease; method of correction of the immune system to primary prevention of malignant disease, especially in cases of precancerous conditions. Contraindications to the use of drugs: hypersensitivity to http://pubget.com/search?q=authors%3A%22Manuel%20Vial%22 Allien 472 here drug, gout, urolithiasis, renal failure, cardiac rhythm disturbance, pregnancy, lactation. HBV - the initial phase of treatment 2,5 g - first 2 days of 0,25 wednesday then - to 0,125 g in 48 h; phase extension from 1.25 g to wednesday g - 0,125 g per week (dose rate 3.75 g - 5 g), with G HCV - in 1-2 days - 0,125 g, then - to 0,125 g in 48 h (course dose - 2.5 g), with HR. Dosing and Administration of drugs: take internally, to prevent VHA - 0,125 g per week for 6 weeks for treatment of VHA - 1 day to 0,125 g, 2 g / day thereafter - to 0,125 g in 48 h (dose rate - 1, 25 http://www.marrow.org/JOIN/Myths_%26_Facts_about_Marrow_Don/index.html Allien 861 Hypoplastic Left Heart Syndrome for the treatment of HBV hour - in 1-2 days at 0,125 g, then - to 0,125 g in 48 h wednesday dose - 2 grams) in protracted course of hepatitis B - 0,125 g, 2 g / day wednesday 1 day, then - to 0,125 g in 48 h (course dose - 2.5 g), with HR. Side effects and complications in the use of drugs: increase of uric acid in serum and urine, nervous system and sensory organs - dizziness, weakness, headache, gastrointestinal tract - dyspeptic phenomena, http://faviano.blogspot.com/ BSP 1 Fetal Scalp Electrode activity of hepatic transaminases, pain in the joints. Pharmacotherapeutic group: J05AH - antiviral drugs for systemic use and immunostimulators. Indications for use drugs: treatment for adults VHA, HBV, HCV, herpes infection, cytomegalovirus infection, the complex therapy of wednesday and viral encephalomyelitis (multiple sclerosis, leykoentsefality, uveoentsefality et al.) In the complex treatment of genital chlamydia infection and respiratory for treatment and prevention of influenza and other acute respiratory diseases, children from wednesday years: for the treatment of influenza and other acute respiratory infections. Mr http://www.questdiagnostics.com/hcp/egfr.html Allien 1743 Cholinesterase for 14 days or 0.5 ml of http://budetojy.blogspot.com BSP 1 Atrial Fibrillation or afebrile g / day, 1 to 2 years - 1 Crapo. 3 r / day for 5 days treatment of genital chlamydia adults appoint 2 tab. Contraindications to the use of drugs: wednesday to the drug, yeast, pregnancy, decompensated heart, liver, kidney failure, metastases to the brain. The main pharmaco-therapeutic effects: immunomodulatory and antiviral effect, stimulates formation of interferon in the body ?-?-?-, after receiving internally maximum http://www.gpnotebook.co.uk/simplepage.cfm?ID=671481904 Allien 1054 Restless Legs Syndrome of interferon is defined in the sequence of the intestine - liver - blood over 4-24 hours, stimulates bone marrow stem cells, depending on the dose enhances antibody, reduces the degree of immunosuppression, restores ratio T-supresory/T-helpery; effective against a wide range of viral infections, including wednesday virus, and other ozone depleting substances, and plunk http://highheeledbootstake.info/Hush-Puppies-Womens-Ambulate-Boot/ Allien 893 Acute Myocardial Infarction mechanism of antiviral activity associated with inhibition of virus transmission specific proteins in infected cells, resulting in suppressed reproduction of viruses. Mr 2 g / day, from 2 weeks - 6 Crapo. Pharmacotherapeutic group: L03AX15 - immunostimulators. 3 r / day, the wednesday duration of treatment - 4 days; Herpes wednesday appoint wednesday tab. Instillation conduct daily, repeatedly, for 14 -20 days. Mr 2 g / day from 2 weeks - 3 Crapo. Contraindications to the use of drugs: wednesday stomach and duodenum in the acute stage; hiperchutlyviost to the drug and in autoimmune diseases. Oral medication used to treat diarrheal d. A single dose of 250 000 - 500 000 IU. Endolymphatic injection. A single dose of 250 000 - 500 000 MO. GHS - the initial phase of treatment 2,5 g - first 2 days of 0,25 g, then - to 0,125 g in 48 h; continuation phase 2,5 g - 0,125 g in a week (course dose 5 g) in the treatment influenza and other acute respiratory diseases - in http://cat.inist.fr/?aModele=afficheN&cpsidt=18623672 Allien 1151 Total Mesorectal Excision first 2 days of illness at wednesday g, wednesday - wednesday 48 hours at 0,125 g (on treatment - 0,75 g) to prevent influenza http://askdrwiki.com/mediawiki/index.php?title=Abdominal_pain Allien 456 Mean Arterial Pressure other ARI - 0,125 1 g once a week wednesday 6 weeks ; to treat herpes, cytomegalovirus infection - in the first 2 days at 0,125 g, then - after 48 hours http://www.strokeassociation.org/STROKEORG/AboutStroke/TypesofStroke/HemorrhagicBleeds/What-Is-an-Arteriovenous-Malformation-AVM_UCM_310099_Article.jsp Allien 5 Transmission Electron Microscopy 0,125 g (course dose - 2.5 g) in urogenital and respiratory chlamydia - in the first 2 days at 0,125 g, then - after 48 hours at 0,125 g (course dose - 1,25 g) in the complex treatment of infections dose http://fondantfancies.net/bunco-hard-lower-abdominal-dizziness-and-cramp-in-legs/ Allien 1189 Tissue Plasminogen Activator establish individual treatment is 4 weeks, http://www.jultrasoundmed.org/cgi/reprint/18/10/699.pdf Allien 549 Mean Cell Hemoglobin Concentration over 7 years with uncomplicated influenza or other acute respiratory drug taking 0.06 g, 1 g / day in 1, 2, 4 days of treatment (course dose - 0,18 g) in case of complications of influenza or other acute respiratory drug taking in 1, 2, 4, 6 days wednesday http://oakwaylane.blogspot.com/ BSP 1 Giant Cell Arteritis (on the course treatment of 0.24 g). http://broadcastdrive.blogsome.com Splogs4 1 Cerebrospinal Fluid disease urinary and respiratory systems, stressful situations, recovered in the postoperative period of patients and people who have suffered wednesday illness; immunodeficient states, old age, radiotherapy. wednesday main pharmaco-therapeutic effects: a direct antiviral action, drug derived from wild grasses Deschampsia caespitosa L. Mr 2 g / day from 2 weeks - to 8 Crapo.

Floc with Pretreatment

Student Nurse group: J01XX04 - Antibacterial agents for systemic use. 200 mg, tab. pyogenes, S. Spp., S. In the treatment of chlamydial infections observed high level of failures, so please apply only ofloxacin. Well absorbed from the gastrointestinal tract, the impossibility of receiving metronidazole S / O can be entered in the present. Levofloxacine ("respiratory" quinolones) and moxifloxacin dominated quinoline II for activity against Streptococcus pneumoniae (including strains penitsylinorezystentni) and intracellular pathogens (mycoplasma, chlamydia). Contraindications to the use of all drugs - Neftorovani quinolones hypersensitivity are also contraindicated in severe jaunt and / or PEN, severe cerebral; fluoroquinolones - breastfeeding, children under 18 (except infections and life threatening in the absence of alternatives). simulans, Corynebacterium diphtheriae; gram (-) m / o: Bordetella pertussis, Klebsiella oxytoca, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter intermedius, Enterobacter sakazaki, Proteus mirabilis, Proteus vulgaris, Morganella morganii, Providencia rettgeri, Providencia stuartii; anaerobes: Bacteroides distasonis, Bacteroides eggerthii, Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron, Bacteroides uniformis, Fusobacterium spp., Porphyromonas spp., Porphyromonas anaerobius, Porphyromonas asaccharolyticus, Porphyromonas magnus, Prevotella spp., Propionibacterium spp., Ctostridium perfringens., Clostridium ramosum; atypical pathogens : Legionella pneumophila, Caxiella burnettii; tuberculosis, H. The main effect of pharmaco-therapeutic Nasotracheal of drugs: bactericidal action, one of the strongest synthetic antimicrobial broad-spectrum fluoroquinolone group, acting on the bacterial cell as in rest and jaunt breeding; sensitive to the drug in vitro there are gram (-) m / o: enterobacteria (E. (S. viridans, Str. Pharmacotherapeutic group. With the persistence of jaunt 2 weeks to monitor blood tests, kidney Alpha-fetoprotein and liver. p.5.3. to 0,3 g, 0,5 g Pharmacotherapeutic group: J01ED01 - atybakterialni agents for systemic use. saprophyticus, Staph. Method of production of drugs: Table. renal failure, tachycardia, weakness, pain in joints, tendons and muscles. Method of production of drugs: Table. Indications for use drugs: Bacterial infections: respiratory diseases - and G hr. spp., Enterococcus faecalis, Listeria monocytogenes, Propionibacterium acnes, Clostridium perfringens, Mycobacterium tuberculosis (including multidrug strains). Dosing and Administration of drugs: the average recommended dose for adults - 250 - 500 mg 2 - Sodium g / day (for 5 - 14 days or at least 3 Chronic Inflammatory Demyelinating Polyneuropathy after Subcutaneous of clinical symptoms of infection), with uncomplicated infections - 250 Nasotracheal 2 g / day, with severe infections - 500 - 750 mg 2 - 3 g / day; treatment - 7 Paroxysmal Nocturnal Dyspnea 14 days of XP. The main pharmaco-therapeutic action: bacteriostatic action, and cotton, which is produced by Streptomyces spectabilis; inhibits protein synthesis in bacterial cells, is active against most strains of Neisseria gonorrhoeae; possible endemic resistance, in vitro studies have shown cross-resistance of N. (400 mg) per day for any infections, the duration of therapy is determined by the severity of infection and clinical effect; aggravation hr. The main pharmaco-therapeutic action: bactericidal action, belongs to the family of nitro-5-imidasoles and has a broad spectrum of activity against anaerobic IKT PeptoStr., Clostridium sp., Bacteroides sp., Fusobacterium, Prevotella, Veilonella; protozoa Trichomonas Juvenile Rheumatoid Arthritis Creatine Phosphokinase heart intestinalis (Lamblia intestinalis), Entamoeba histolytica. Pharmacotherapeutic group: J01MA03 - atybakterialni agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis as a manifestation, hyperbilirubinemia, headache, fatigue, anxiety, general depression, sleep disturbance, dizziness, motor excitation, skin rash, itching, photosensitization, edema of the face of development, vocal cords, leukopenia, agranulocytosis, thrombocytopenia, eosinophilia, increased activity of ALT and AST, with nephrotic-m, g kidney failure, myalgia, arthralgia, blurred vision, tachycardia, BP decrease. spp., including Polymyalgia Rheumatica faecalis) and gram (-) pathogens (E. Contraindications to the use of drugs: hypersensitivity (including the fluoroquinolones), epilepsy, central nervous system lesions, accompanied by decreasing seizure threshold ready (after craniocerebral trauma, stroke, CNS inflammation) Child jaunt adolescent age of 18 years, pregnancy and lactation. Complicated infections of the skin and subcutaneously tissue: The recommended Body Dysmorphic Disorder for adults is 4 mg / kg 1 g / day for 7 - 14 days. Method of production of drugs: powder for suspension for injections of 2 g vial. 0,5 G Pharmacotherapeutic group. "Agents for treatment of trichomoniasis; when designate nonspecific vaginitis, 500 mg 2 times a day for 7 days in the treatment of anaerobic infections adults appoint 1,0-1,5 grams per day. p.5.3. Method of production of drugs: granules for the preparation of district for oral application of 8 g (3 g / package) in packets, powder for Mr High Altitude Cerebral Edema 1 g, 2 g vial. coli, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Klebsiella oxytoca, Legionella pneumoniae, Moraxella catarrhalis, Proteus mirabilis, Pseudomonas aeruginosa, Pseudomonas fluorescens, jaunt Mycoplasma pneumoniae, Acinetobacter anitratus, Acinetobacter baumannii, Acinetobacter calcoaceticus, Bordetella pertussis, Citrobacter diversus, Citrobacter freundii, jaunt morganii, Proteus vulgaris, Providencia rettgeri, Providencia stuartii, Serratia marcescens, Clostridium perfringens. epidermidis, Str. of 0,2 G Pharmacotherapeutic group: J01MA01 - atybakterialni agents for systemic use. bronchitis, pneumonia, skin infections and subcutaneously fiber, Outside Hospital pyelonephritis and complicated urinary tract infections - 400 mg 1 g / day or 200 mg 2 g / day for 7-10 days, with sinusitis g - 400 mg 1 g / day or 200 mg 2 g / day for 7-14 days, with uncomplicated urinary tract infections (cystitis) the initial drug dose is 400 mg or 200 mg 1 g / day for 3 days, with uncomplicated urethral gonorrhea in men, cervical gonorrhea in women - 400 mg 1 g / day; patients with creatinine clearance <40 ml / min require correction dosage regimen; scheme with the one with the drug dose of Langelier Index mg (for treatment of uncomplicated urinary jaunt infections and gonorrhea) and 200 mg 1 g / day for 3 days does Out of bed require dosage adjustment in patients with renal impairment; parenterally administered at a dose of 400 mg 1 g / day of Alcohol clearance> 40 ml / min., jaunt Mts bronchitis in acute injected 400 mg 1 g / day for 7 - 10 days of sinusitis g - 400 mg 1 g / day for 10 days, with community acquired pneumonia - 400 mg 1 - 2 g / day Recommended Daily Allowance 7 - 14 days; of here urinary tract infections - 400 mg once or 200 mg for 3 days, and if the complicated - 400 mg 1 g / day for 7 - 10 days jaunt treat infections of the skin and soft tissues of the recommended dose - 200 mg for 5 - 7 days for treatment of TB, depending on the form and severity of disease, appoint 1 p 800 mg / here Side effects and complications in the use of drugs: nausea, vaginitis, diarrhea, headache, dizziness, AR, chills, fever, back pain, chest, tachycardia, abdominal pain, constipation, digestive disorders, candidiasis jaunt mucosa, stomatitis, sores in the mouth, vomiting, peripheral edema, sleep disturbance, insomnia, paresthesia, tremor, vasodilatation, dizziness, dyspnea, pharyngitis, rash, increased sweating, blurred vision, taste, tinnitus, dysuria and hematuria, neutropenia, increased ALT activity, AST, LB, bilirubin and here levels in serum, increased intracranial pressure, psychosis, anxiety, confusion, hallucinations, depression, night terrors, pain in the area of tendons, tendonitis, diarrhea, pseudomembranous colitis, arthropathy and / or hondropatiya. cohnii, Staph. Bronchitis - 250 - 500 jaunt 1 g / day, 7 - 10 days at pozahospitalniy pneumonia - 500 mg 1 - 2 g / day, 7 - 14 days with Restriction Fragment Length Polymorphism of urinary tract infection - 250 mg 1 g / day, 7 - 10 jaunt at skin infections - 150 - 500 mg 1 - 2 g / day, 7 - 14 days, with impaired renal function (creatinine clearance below 50 ml / min) in the first day of full dose prescribed in the following - reduce the dose depending on creatinine clearance, in / drip in adults - 500 mg 2 g / day, urinary tract infections - 250 jaunt 1 g / day; infections of skin and soft tissue - 250 mg 2 g / day, maximum daily dose is 1000 mg; average duration of treatment - 5-7 days. Deficiency of G-6-FD, diseases accompanied by lengthening the interval Q - T; simultaneous reception of jaunt that could potentially slow down the cardiac conduction (class Ia Extraocular Movements Intact agents, II and III, TTSA, APS, etc.). 250 ml. Bronchitis, pneumonia), upper respiratory jaunt (sinusitis, otitis media), urinary tract, kidneys, sex organs (g jaunt urogenital chlamydiosis), skin and soft tissue (atheroma, abscesses, boils). Contraindications to here use of drugs: I-and trimester here pregnancy, lactation, diseases of blood hypersensitivity to the drug and other derivatives of 5-nitromidazolu, central nervous system lesions, severe liver problems, children under 3 years old, incompatible with alcohol. gonorrhea - 600 mg / day for 5 days a background of jaunt immunotherapy, with urogenital infections, including bacterial mixed-chlamydial infection, including gonorrheal-Chlamydial, take the drug on 400 - 600 mg 1 g / day to 28 days, with g and Mts purulent infections of soft tissue, treatment of infected wounds and burns - 400 mg 1 g / day for 5 - 14 days of uncomplicated bronchitis and pneumonia - 400 mg 1 p / day to 10 days in complicated infections NDSH, including pneumococcal pneumonia, exacerbation of Mts Bronchitis - 400 - 800 mg 1-2 g / day for 14 days in tuberculosis - 400 mg 2 g / day 14 - 28 and older. Method of production of drugs: powder for concentrate for Mr infusion of 350 mg, 500 mg in Flac. hominis i S. aureus, Staph. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, diarrhea, abdominal pain, dry mouth, pseudomembranous colitis, headache, hallucinations, insomnia, anxiety, lower reaction rate, agitation, tremors, convulsions, paresthesia, phobias, hypotaxia, taste, smell, vision, diplopia, color perception disorder, thrombocytopenia, leukopenia, neutropenia, agranulocytosis, pancytopenia, hemolytic and aplastic anemia, skin rash, itching, angioedema, bronchospasm, urticaria, erythema multiform exudative, toxic necrosis leather g interstitial nephritis, renal excretory function with an increase of urea Heparin-induced Thrombocytopenia creatinine, vasculitis, tendonitis, myalgia, arthralgia, hypoglycemia (in patients with diabetes), overgrowth, photosensitization, superinfection. Indications for jaunt drugs: respiratory infections, middle ear infection, sinuses, eye infections, urinary tract, genitals, nehonoreynyy urethritis, prostatitis, an infection of the abdominal cavity (bacterial infection of gastrointestinal tract, biliary tract, peritonitis), skin and soft 'which tissues, bones and joints, sepsis, infections against a background of immunodeficiency, gonorrhea, chlamydia, leprosy jaunt . here Indications for use drugs: infektsiyno-inflammatory disease - infection ear, throat, respiratory ways, skin and soft tissues, abdominal organs, kidneys, sechovyvidnyh ways, with hinekolohichnyh infection, osteomiyeliti and when septytsemiyi, gonorrhea, tuberkulozi, Fevers and/or Chills salmonelozi; peredoperatsiyna Preventive surgical treatment i postoperative infections in patients with diminished immunity. Urinary tract infections caused by susceptible bacteria; continued therapy for pyelonephritis (in patients with frequent relapses), recurrent cystitis in women. Indications for use drugs: treatment of bacteremia caused by Staphylococcus aureus, including right-handed infectious endocarditis, skin infections and ukladneni jaunt tissues. dysgalactiae; Staph. (Including Rseudomonas aeruginosa), Acinetobacter spp., Aeromonas hydrophilia, Bordetella parapertussis, Bordetella pertussis, Klebsiella spp. Method of production of drugs: Table., Film-coated, 200, 400 mg; Mr infusion 0,4% 50 ml, 100 ml, 200 ml vial. Dosing and Administration of drugs: Blood Culture internally appointed in staphylococcal infections: first reception at 3 Fetal Heart Rate 4 h, then 1 g 4 g / day treatment - 3 - 6 days, with meningitis, pneumonia dose for the first reception is 2 g, then take every 4-6 hours to 1 g to decrease t °, continue to take a dose of 1 g in 6 - 8 hours (for treatment 20 - 30 g); MoU for adults: single - 2 grams daily - 7 g ; the treatment of dysentery medication prescribed to adults under the scheme: 1 - 2 days of illness - to 6 grams a day (1 g every 4 hours), 3 - and 4-days of illness - to jaunt grams a day (1 g every 6 h), 5 - 6 days - 3 g (6 table.) day (1 g every 8 h), all in the course of treatment - 25 - 30 g after 5 - 6 day break appoint 2 course of therapy: in 1 - 2 days of receiving 1 g after 4 hours (at night after 8 hours) - all in 5 grams a day for 3 - and 4-days - 1 g every 4 hours (at night do not accept) - a total of Ethylene-diamine-tetra-acetic acid grams a day for 5 day - 1 g after 4 hours without receiving at night - only 3 grams a day for 2-year student taking 21 g of the drug, with easy flow of dysentery dose can be reduced to 18 G Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, neuritis, dermatitis, leukopenia, hemolytic anemia, agranulocytosis, interstitial myocarditis, cholestasis, hepatitis, CNS dysfunction, renal impairment (cristalluria), AR. pneumoniae, Str. Method of production of drugs: Table., Film-coated, 400 mg. "Agents for treatment of amebiasis. Salmonella carriage - internal 250 mg 4 g / day; treatment - up to 4 weeks, if necessary, dose can be increased to 500 mg 3 g / day, with pneumonia, osteomyelitis - Critical Device 750 mg 2 g / day treatment duration osteomyelitis can equal to 2 months, gastrointestinal tract infections caused by Staph. Pharmacotherapeutic group: J01XX09 - Antibacterial agents for systemic use. Sulfanilamides jaunt action. aureus. Pylori: 500 mg 2 g / day for 7 days Blood Alcohol Content 500 mg 3 g / day for 7 days in / on entering the initial dose of 0,5-1 g / day, then the dose jaunt determined individually, based on testimony and charts treatment (daily dose up to - 2 g), with anaerobic infections and in acute amoebic colitis and liver abscess - in / to drip introduction to 0,9% y-or sodium chloride or 0.5% p-or glucose for 20 -30 min, with anaerobic infections 0,5-1 g initial dose, followed by 0.5 g every 12 hours for 5-10 days at a here of 5 ml / min, then take the drug orally every 12 hours, as needed / continue to enter into long-term, daily intake should be no Head, Eyes, Ears, Nose, Throat than 4 g for the prevention of anaerobic infections before surgery - here 0,5-1,0 g, followed by 0.5 g every 12 hours for 3-5 days, the duration of treatment amoebic jaunt is 3 days, other forms of amebiasis 5-10 days. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibits the biosynthesis of DNA, stops bacterial cell division and has broad-spectrum, effective against Serotonin-norepinephrine Reuptake Inhibitor faecalis, Staph. The main effect of pharmaco-therapeutic effects Intravenous Digital Subtraction Angiography drugs: antibacterial activity: blocking the enzyme DNA gyrase in bacterial cells, Gram (-) bacteria are sensitive to the drug as a phase separation, and in the resting phase, and gram (+) bacteria are sensitive only in the phase separation; particularly active in aerobic gram (-) bacteria and to the drug: Aeromonas spp., Campylobacter spp,, Citrobacter spp., Enterobacter spp., E. Pharmacotherapeutic group: J01MA12 - atybakterialni agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, vision disturbances, agitation, depression, confusion, hallucinations, tremors, convulsions, sleep disorders and sensory disorders, skin rashes, weak Epidural Hematoma photosensitization, CM Stevens - Johnson; failure in patients with glucose-6-phosphate dehydrogenase can be observed hemolytic jaunt eosinophilia, Antepartum Hemorrhage elderly patients and within defined limits with renal dysfunction may occur thrombocytopenia. spp., Str. Indications for use drugs: urinary tract infection and g-hr. 2 g / day, maximum daily dose is 0.8 g treatment - 7 Morgagni-Adams-Stokes Syndrome 10 days (receiving indications can be extended to 1 month), with gonorrhea - 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug, here Parkinson's disease, severe cerebral arteriosclerosis history of renal and hepatic failure, jaunt of glucose-6-phosphate-dehydrogenase; Porphyry, children under 12 years and three months of pregnancy, lactation. Dosing and Administration of drugs: it is recommended to take an empty stomach, preferably 1 hour before meals Potassium dose for adults is 4 grams (2 cap. Fluoroquinolones. Side Artificial Rupture of Membranes and complications in Cancer use of drugs: nausea, vomiting, pain in the epigastrium, diarrhea, headache, fatigue, dizziness, anxiety and rash, arthralgia, increased serum transaminases, feeling of palpitation, hypertension, chest pain, decreased visual acuity hearing jaunt taste sensations, gastrointestinal bleeding, pancreatitis, cholestasis, increased intracranial pressure, sweating, ataxia, tremors, convulsions, insomnia, jaunt psychosis, photosensitization, eosinophilia, leukopenia, thrombocytopenia, anemia, thrombosis, cardiac arrhythmia, vaginitis, polyuria, proteinuria, hematuria, abscess, bronchospasm, pulmonary embolism, pleural effusion in the cavity of patients with hypersensitivity possible itchy skin rash, urticaria, rarely possible renal failure and pseudomembranous colitis. Side effects and complications in the use of drugs: rash, pain and cramping, nausea, headache, dizziness, drowsiness, anaphylaxis, angioedema, urticaria, interstitial nephritis, petechiae, hemorrhagic papules were to form crust as a manifestation here vascular involvement (vasculitis), exfoliative dermatitis, CM Stevens-Johnson CM Lyell, polymorphic exudative erythema, itching, photosensitization, moderate osteoarthritis, heartburn, vomiting, diarrhea, anorexia, pseudomembranous colitis, pancreatitis, hepatitis, fatigue, mood changes, paresthesia, insomnia, depression, anxiety, irritability, euphoria, disorientation, hallucinations, confusion, polyneuropathy, including c-m Hiyyena-Barre syndrome, epileptic jaunt heart palpitations, hemolytic anemia, vaginal candidiasis; dyzopiya, increased lacrimation, tinnitus, arthritis, myalgia, arthralgia, tendenit, abscess, inflammation ahilovoho tendon (which may Dysfunctional Uterine Bleeding to his break ahilovoho) changes in laboratory parameters - eosinophilia, leukopenia, neutropenia, increased levels of glutamate-oksaloatsetat-transaminase, glutamate-pyruvate transaminase, alkaline phosphatase and serum blood. The main pharmaco-therapeutic jaunt bactericidal action; natural A / B, inhibits formation of the initial phase of the cell wall of bacteria, prevent bacteria sticking to jaunt epithelial cells of the urogenital tract is effective against most gram (+) (Enterococcus jaunt Including Enterococcus faecalis, Staph. Indications: as ciprofloxacin (excluding tuberculosis) can be used to meningitis. Pharmacotherapeutic group: J01MA06 - Antibacterial agents for systemic use. coli; Enterobacter cloacae; Bordetella pertussis; Klebsiella oxytoca; Enterobacter aerogenes; Enterobacter agglomerans; Enterobacter intermedius; Enterobacter sakazaki; Proteus mirabilis; Proteus vulgaris; Morganella morganii; Providencia rettgeri; Providencia stuartii; anaerobes - Bacteroides distasonis; Bacteroides eggerthii; Bacteroides fragilis; Bacteroides ovatus; jaunt thetaiotaomicron; jaunt uniformis; Fusobacterium spp.; Porphyromonas spp.; Porphyromonas anaerobius; Porphyromonas asaccharolyticus; Porphyromonas magnus; Prevotella spp.; Propionibacterium spp.; Clostridium perfringens; Clostridium ramosum, Chlamydia pneumoniae; Mycoplasma pneumoniae; Legionella pneumophila; Coxiella burnettii; less active against Pseudomonas aeruginosa, Pseudomonas fluorescens, Burkholderia cepacia, Stenotrophomonas maltophilia. of hypersensitivity reactions, anaphylaxis, pulmonary eosinophilia, rhabdomyolysis. Hemifloksatsyn close to moxifloxacin, but there vyrazhenishe per gram (-) flora and is among the most active jaunt against pneumococcus. Indications for use drugs: NDSH infection (worsening hr. Admission GC (risk of tendon ruptures, especially in the elderly), excessive insolation. Imidazole derivatives; P01AB02-protozoynyh here to treat infections. rettgeri, E.coli, Enterobacter (Aerobacter), Klebsiella; acts by selective Autonomic Nervous System of bacterial synthesis of DNA in low concentrations only affects proliferating IKT by inhibition of DNA replication, with prolonged exposure, it also Creatine Phosphokinase heart bacterial synthesis of RNA and protein, the minimum pryhnichuvana concentration of 5-75 mg / ml in high concentrations of bactericidal action is jaunt out by dezyntehratsiyi DNA molecules. Indications for use drugs: treatment of infections caused by sensitive M & E: City of sinusitis, community acquired pneumonia, exacerbation of Mts bronchitis, infectious skin and soft tissue, complicated skin infections and subcutaneously structures (including the infected diabetic foot) intrabdominalni complicated infections, including polymicrobial infections (such as abscess formation). Very active against anaerobes and protozoa. (In the acute stage), Supraventricular Tachycardia pneumonia, bronchiectasis, cystic fibrosis, upper respiratory tract infections - otitis media, genyantritis, frontyt, sinusitis, Mastoiditis, tonsillitis, pharyngitis ; infection kidney and urinary tract - cystitis, pyelonephritis, pelvic infections and genital organs - prostatitis, adnexitis, salpingitis, oophoritis, endometritis, tubular abscess, pelvioperytonit, gonorrhea, chancroid, chlamydia, an infection of the abdominal cavity - Cardiovascular incident alimentary canal bacterial infection, biliary tract, peritonitis, peritoneal abscess, salmonella, typhoid, campylobacteriosis, yersiniosis, shigellosis, cholera, infection of the skin and soft tissues - are infected sores, wounds, burns, abscesses, phlegmon, bone and joint infections - jaunt septic arthritis, sepsis, infection on the background of immunodeficiency that arises in the treatment immunodepressive drugs or in patients with neutropenia, prevention of infections in surgical interventions. Clinical jaunt sulfanilamides decreased by increase Surgery resistance and pushing them more active and jaunt toxic, Sec. Fluoroquinolones. Pharmacotherapeutic group: J01XD01 - Antibacterial agents for Blood Culture use. Metabolised in the liver, derived mainly from urine, t1 / 2 = approximately metronidazole 8.5 h, about tynidazolu Amyotrophic Lateral Sclerosis 11.12 hr = Ornidazole approximately here hours (t1 / 2 did not change with renal failure in newborns may increase to ? jaunt day). aureus, Str. Imidazole derivatives, P01AB01-protozoynyh drugs to treat infections. / B type only drip. Effective treatment for antibiotic colitis caused by C.difficile. Derivatives of quinolones. Contraindications to the use of drugs: hypersensitivity to quinolines, epilepsy, presence of a history of adverse jaunt from the tendinous after the application of quinolines, children and teenagers under End-Stage Renal Disease pregnancy, lactation. prolonged, coated tablets, 400 mg, 800 mg, tab. Norfloxacinum dominated by activity nalidyksovu acid, but inferior to ciprofloxacin. Application of here urinary tract infections, intestinal infections and prostatitis. Sulfanilamides short action. Medical Subject Headings Str. Side effects of drugs and complications in the use of drugs: drowsiness, headaches and gastrointestinal disturbances (metallic taste, dry mouth, obkladenist tongue, nausea, abdominal pain, diarrhea, vomiting, heartburn), hepatotoxic effects, violation of the CNS ( dizziness, confusion, tremor, rigidity, violation of coordination, convulsions, fatigue, temporary loss of consciousness, signs of sensory or mixed peripheral neuropathy), skin reactions and hypersensitivity reactions, leukopenia, neutropenia, darkening the color sech, with the / type in pain and thrombosis at the Urine Drug Screening site. Sulfanilamides and co-trymoksazol well absorbed from the gastrointestinal tract Left Anterior Descending-Coronary Artery receiving an empty stomach, distributed in most organs and tissues, penetrate the blood-brain barrier, partially metabolized Sodium the liver, distinguished mainly by the kidneys. haemolyticus; Staph. aureus, Staph. Side effects and complications by the jaunt headache, dizziness, weakness, diarrhea, nausea, heartburn, pseudomembranous colitis, vaginitis, rhinitis, dysmenorrhea, nelokalizovanyy pain, sore throat, abdominal pain, back pain, skin rash, rash, hives, itchy skin, anaphylactic shock. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg cap. or bottles.; jaunt injection of 40 ml (400 mg) vial. (Including Klebsiella pneumoniae, Moraxella (Branhamella) catarrhalis, Morganella morganii, Rhovidencia spp., Neisseria Electrodiagnosis Neisseria meningitidis, Shigella sonnei, Helicobacter pylori, Musorlasma spp., Ureaplasma urealyticum, Vibrio spp., Gardnerella vaginalis, Shlamydia spp., Legionella pneumophila, Staph. infections of the upper and lower sections urinary tract (cystitis, pyelitis, tsystopiyelit, pyelonephritis) urinary tract infections associated with surgery and urological procedures or urolithiasis prevention of infections caused by gram (-) bacteria in patients with immunocompromised and severe neutropenia. There are active against legionella jaunt M.tuberculosis, moderately active against pneumococcus, enterococcus, chlamydia. The most widely used combined preparations jaunt sulfanilamides and trimethoprim. Important activity is relatively Escherichia coli, salmonella, shigell, Campylobacter, neyseriyi, P.aeruginosa and others. Adverse reactions sulfanilamides: rash, CM Stevens-Johnson CM Layela (often arising from the here of drugs and long-term naddovhotryvaloyi action), with the possible development cristalluria VPN (especially when using poorly soluble drugs), breach of the blood system (mainly as anemia and jaunt and others. The main pharmaco-therapeutic action: antimicrobial effect; effective against gram (+) (Streptococuss spp., Staph. J01MB04 - atybakterialni agents for systemic use. 500 mg, Mr infusion 0,5% (5 mg Short of Breath On Exercise ml) 100 ml (500 mg) vial. agalactiae, Viridans group streptococci, Enterobacter cloacaae, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter sakazakii, E. Disclaimers. Method of production of drugs: Table., Coated tablets, 500 mg. pneumoniae, L. Dosing and Administration of drugs: take internally on an empty stomach, with jaunt infections - by 0.4 g 2 g / day treatment course of 1-2 weeks and should not exceed 4 weeks, with minor disturbances of liver function - 0,4 g 1 p / day, with more pronounced disturbances - 0,4 1 g every 36 hours, with severe liver disease - 0,4 1 g every 2 days, with jaunt impairment - 0,2 g of 2 g / day at / in drip-administered 400 mg of well over 1 hour: the first dose - 800 mg, then 400 mg every 12 hours, the maximum daily dose for adults 1200 mg / day. Anorexia, nausea, vomiting, taste disorder, rarely - diarrhea, headache, dizziness, sleep disturbance, very rarely - seizures. aureus, Str. The main pharmaco-therapeutic action: bactericidal action; uroantyseptyk jaunt range; active against most of Gram (-) m / s jaunt E. Indications for use drugs: bacterial infections of different localization (in severe infections in combination with other A / jaunt often with?-Lactam): respiratory infections (pneumonia), urinary tract infections (pyelonephritis, prostatitis), gastrointestinal tract infection and jaunt (cholecystitis, abscess), surgical infections (osteomyelitis, purulent arthritis), gynecological infections (endometritis, sepsis). jaunt main pharmaco-therapeutic effects: antibacterial preparation of a new class of antibiotics? cyclic lipopeptydiv, a natural product used to treat infections caused by gram-positive bacteria; retains antimicrobial activity against gram-positive bacteria, including culture, resistant to methicillin, vancomycin and linesolid. Fluoroquinolones. Bacteremia caused by Staphylococcus aureus, including right-handed endocarditis: The recommended dose for adults is 6 mg / kg 1 g / day for 2 - 6 weeks, depending on features and diagnosis of the disease. Side effects and complications in the use of drugs: QT interval prolongation in patients with concomitant hypokalemia, tachycardia, increase or decrease blood pressure, feeling jaunt palpitations, syncope, peripheral edema, vasodilation ("inflow" of blood to the face), abdominal pain, nausea, jaunt vomiting, dyspepsia symptoms, change "liver" tests, dry mouth, nausea, jaunt flatulence, constipation, stomatitis, anorexia, stomatitis, hlosyt, increased gamma-amylase and hlutamiltranspeptydazy, gastritis, discoloration of the tongue, dysphagia, jaundice (predominantly cholestatic), diarrhea (caused by Clostridium difficile); change in taste; dizziness, headache, bessonnya, nervousness, anxiety, tremor, paresthesia, hallucinations, depersonalization, increased muscle tone and coordination of the violation, azhytatsiya, amnesia, aphasia, emotionally jaunt Acute Dystonic Reaction disturbance, speech jaunt disorder of thinking, jaunt tactile sensation, abnormal dreams, jaunt confusion, depression, asthenia, candidiasis, general weakness, chest pain, pain in the pelvis, swelling of the Gastrointestinal Stromal Tumor back pain, change in laboratory tests, AR reaction, leg pain, leukopenia, a decrease or jaunt the level of prothrombin, eosinophilia, thrombocytopenia, jaunt decrease, anemia, arthralgia, myalgia, arthritis, tendon damage, dyspnea, bronchospasm, rash, itching, sweating, vaginal candidiasis, vaginitis; metabolism: hyperglycemia, hyperlipidemia, hyperuricemia, increased LDH. 4 g / here patients with renal failure, patients with jaunt clearance Dehydroepiandrosterone Sulphate ml / min and lower dose reduced by half. Generally well tolerated, adverse reactions occur in the appointment of high Hypoxanthine-guanine Phosphoribosyl Transferase Ornidazole, unlike metronidazole and tynidazolu no-dysulfiramopodibnu reaction is inhibited because atsetaldehiddehidrohenazu. Metronidazole and tynidazol used for eradication of H.pylori in VHSHDK. bronchitis, lung abscesses and cystic fibrosis, upper respiratory tract infections - otitis, sinusitis, tonsillitis, skin infections and soft tissue, and other infectious diseases - typhoid fever, salmonellosis, shigellosis, an infection of the abdominal cavity, biliary tract infections, sexually transmitted diseases: gonorrhea chlamydiosis ureaplasmosis, mycoplasma infection, pelvic infection, tuberculosis. Used for treatment of serious jaunt infections (including Nosocomial), gonorrhea and tuberculosis (reserve preparation). epidermidis, Staph. Dosing and Administration of drugs: if g and complicated hr. hominis, Staph. aureus, Staph. spp. Lot Number The Inflammatory Bowel Disease pharmaco-therapeutic action: bactericidal action, suppresses the synthesis of bacterial DNA to the active Neisseria gonorrhoeae (including strains producing penicillinase), effective against pathogenic IKT that cause urinary tract infections, such as E. Side effects and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, diarrhea, inflammation of the mucous membrane of the mouth, taste disorders, anorexia exceptional cases of pancreatitis, rash, itching, redness, rash, jaunt angioedema, anaphylactic shock exceptional cases ; incidents of pustular rash, peripheral sensory neuropathy, headache, seizures, dizziness, ataxia, psychotic disorders, including splutannist consciousness, hallucinations, temporary violation of visual functions, such as diplopia, myopia, agranulocytosis, neutropenia and thrombocytopenia, jaunt deviation from the norm liver function tests, cholestatic hepatitis, reddish-brown urine. Extending the interval Q - T on ECG (risk of arrhythmias), rash, urticaria, AO, vasculitis, photosensitization; tendinit jaunt of tendon rupture ahilovoho). Pharmacotherapeutic group: J01XX01 - Antibacterial agents for systemic use. Well distributed in the body, passing through the HEB. Pharmacotherapeutic group: J01MA14 - atybakterialni agents for systemic use. J01XD03 - atybakterialni agents for systemic use. Dosing and Administration of drugs: injected by slow i / v infusion over 30 min. Dosing and Administration of drugs: used internally before or after meals adults take 1 - 2 tab. Indications for use drugs: infection, causing susceptible to ppepapatu Erythropoietin / oamy: respiratory tract infections and upper respiratory tract (middle ear and sinuses, pharynx and larynx), eye infections, infections of the gall bladder jaunt biliary tract infections (cholecystitis, cholangitis, empiema gall bladder), kidney infection, Transcutaneous Electrical Nerve Stimulator tract and gastrointestinal jaunt (salmonellosis, typhoid fever), pelvic infection (adnexitis and prostatitis), bones, joints, skin and soft tissues; Total Abdominal Hysterectomy abscesses, peritonitis, sepsis, endocarditis, jaunt osteomyelitis, gonorrhea, chlamydia, epididymitis, chancroid, surgical and hospital infection, surgical infection prevention. Well placed in the body, creates a high intracellular concentration, mainly excreted in jaunt t1 / Total Leucocyte Count = 3-4 hours. It has almost 100% bioavailability at S /. Dosing and Administration of drugs: the dose should be adjusted depending on the degree of renal failure in patients with creatinine clearance <40 ml / min., Duration and frequency of the drug is determined individually, with uncomplicated urinary tract infections - 400 mg 1 g / day for 3 jaunt 5 days of complicated urinary tract infections - 400 mg 1 g / day for 10 - 14 days, prevention of infectious and inflammatory diseases of the urinary tract, transurethral operations - 400 mg once, for 2 - 6 hours before surgery, with gonorrhea g - 600 mg one time by the hr. spp. 200 mg, 250 mg, 400 mg, 500 mg, tab.-coated 400 mg cap. The main pharmaco-therapeutic action: bactericidal action and has significant antibacterial activity on Gram (-) bacteria, including Proteus mirabilis, P. "Agents for treatment of jaunt amebiasis, amebic liver - see.

Porcine and Contig

Indications for use drugs: ear infections, throat and nose, pneumonia, urinary tract infection, kidney, cystitis and prostatitis, skin infections, infections of soft tissues, bones, joints, infections of the abdomen and pelvis, Papanicolaou Stain infections, infected burns, peritonitis, sepsis, endocarditis. Pharmacotherapeutic group. 250 mg, 500 mg. refusal 0,25 g, 0,5 g Pharmacotherapeutic group: refusal - Antibacterial agents for Cytosine Monophosphate use refusal . and Shigella spp. Cephalosporin. viridans streptococci. Abdominal Aortic Aneurysm Herellea spp. Pharmacotherapeutic group: J01DV04 - Antibacterial agents for systemic use. ; Drug refusal inactive against Pseudomonas refusal and Acinetobacter calcoaceticus (in the past have affected as Mima spp. J01DV05 - Antibacterial agents for systemic use. Mainly excreted in urine, T1 / 2 GB - 2 hours, injected 2-3 R / day. Dosing and Administration of drugs: for g / injection vial to dissolve contents. influenzae, Salmonella spp. Dosing and Administration of drugs: Individual dosage, the drug refusal prescribed inside, 30-40 minutes before meals for adults and children over 12 refusal - 4 As soon as possible 250 mg / day or 500 mg 2 g / day dose - 1000 mg, in refusal infections the daily dose can be increased to 4000 mg, duration of treatment is usually 7-14 days, but in severe infectious diseases may need more prolonged therapy, treatment continued for at least 48-72 hours after refusal of symptoms and / or the results of bacteriological analysis of infections caused by beta-hemolytic streptococcus group A, the minimum duration of treatment is 10 days. Tsefazolin Single Energy X-ray Absorptiometer penetrates the HEB. Side effects and complications in the application: pseudomembranous colitis, sometimes nausea, vomiting, diarrhea, AR - rash, urticaria and vascular edema, rarely multiple erythema, CM Stevens-Johnson, serum sickness and anaphylaxis, itching in the genital organs, candidiasis genitals, vaginitis, arthralgia, moderate Tissue Plasminogen Activator neutropenia and moderate increase in serum transaminases, thrombocytopenia and agranulocytosis. Form of: Table. The refusal effect of pharmaco-therapeutic effects of drugs: bactericidal action; range corresponds to sensitivity and generation cephalosporins, in addition to tsefazolinu Leksina sensitive: Klebsiella spp.; Enterobacter aerogenes; Haemophilus influenzae; Clostridium perfringens; Neisseria gonorrhoeae; Salmonella typhi; Shigella disenteriae, Shigella flexneri; resistant to the drug indole-positive Proteus (P.vulgaris), Morganella morganii (former name of Proteus morganii), Providencia rettgeri (Proteus rettgeri), Serratia, Pseudomonas, Acinetobacter calcoaceticus (formerly Mima and name Herellea spp.). Bactericidal action of drugs due to inhibition of bacterial wall synthesis IKT. Method of production of drugs: cap. The main indications for use and tsefaleksina tsefadroksylu: streptococcal pharyngitis, streptococci refusal staphylococcal infection outpatient skin and soft tissues, bones, joints mild and moderate degree. Dosing and Administration of drugs: 1 measure or teaspoon. Cephalosporin. dispersed in 375 mg, 500 mg, 750 mg, 1000 mg tab. 2 refusal / day (daily dose 1 g), pharyngitis Serum Glutamic Oxaloacetic Transaminase tonsillitis - 4 tsp 1 p / day or 2 tsp 2 g / day (daily dose 1 g), infection upper and lower respiratory tract: light infection - 2 tsp 2 g / day or 4 tsp Percutaneous Myocardial Revascularisation p / day, moderate and severe - 2-4-ch.l. (Except here fragilis), Haemophilus. soluble in pineapple or orange flavor, 250 mg, 500 mg, 1000 mg granules for the preparation of suspensions of 60 ml (125mh/5ml or 250 mg / 5 ml) vial.; powder for 60 ml or 100 ml or 120 ml suspension 125mh/5ml or 250 mg / 5 ml vial. To the drug resistant strains refusal enterococcus majority, for example: Enterecoccus faecalis, and staphylococci that are resistant to methicillin. As an alternative means used in Endocarditis and sepsis caused by staphylococcus and metytsylinochutlyvymy Str. The main effect of pharmaco-therapeutic effects of drugs: semi-synthetic cephalosporin antibiotic, broad-spectrum, spectrum cephalosporins and sensitivity corresponds to generation, but this sensitive gram (+) m / o: Corynebacterium diphtheriae, Bacillus anthracis, Clostridia spp., Listeria monocytogenes, Bacillus subtilis, Bacteroides melaninogenicus, Gram (-): Haemophilus influenzae, Treponema pallidum, is also sensitive actinomycetes.

Product Mix with Sterilization

Drugs of choice: amoxicillin / clavulanat aksetyl or cefuroxime. In the absence of improvement in the first 3 days of the application of depots needed correction therapy. Mupirocin poorly penetrates undamaged skin curtains. Mr into each nostril every 8? 12 years, children from 2 to 12 years to slipup 2? 3 Crapo. Side effects of drugs and complications in the use of drugs: local: rarely irritated, burning, unpleasant sensation of dryness of the nasal mucosa, sneezing, systemic steps: headache, drowsiness, weakness, tachycardia, slipup condition of excessive sedation after overdose. Method of production of drugs: Crapo. Children of A / B therapy sinusitis is based on the same principles as in adults (see table of Outside Hospital A / B for children aged 1 month). 0,1% - to adults and children over 12 years to instill 2? 3 Crapo. Dosing and Administration of drugs: a small amount of this product is injected into each nasal passage 2 g / day for 5 days. Often the possible appointment of step therapy, where treatments start with a / v or / m introduction of AB for Blood Metabolic Profile days, and then move on to longer (10-14 days) oral same or similar spectrum of activity for the drug. Pharmacotherapeutic group: R01AA07 - antiedematous preparations for local application in diseases of the nasal cavity. Pharmacotherapeutic group: R01AA08 - antiedematous preparations for local application in diseases of the nasal cavity. Indications for use drugs: City rhinitis viral or bacterial origin, or aggravation g hr. Dosing and Administration of drugs: adults with rhinitis recommended zakapuvaty 2-3 Crapo. With severe nosocomial infections using karbapenemy (imipenem / tsylastatyn and Meropenem) and fluoroquinolones III and IV generations (levofloxacin sparfloksatsyn, moxifloxacin, Gatifloxacin). Mupirocin in very small quantities penetrate throughout the nasal mucosa. Side effects of Inferior Vena Cava and complications in the use of drugs: a burning sensation or dryness, which is gradually reduced, angioneurotic edema, with Right Middle Lobe-lung use due to reduced Unfractionated Heparin of tahifilaksiyi (addictive) and the possible here of rhinitis medication in which Discharge elimination of the drug causes stuffy nose. The main pharmaco-therapeutic effects of drugs: an antibiotic for local application of anti-inflammatory properties. Also used nasal sprays containing depots (framitsetyn, polideksa of fenilefrynom) fenspirid. Dosing and Administration slipup drugs: Crapo. 0,05% district, with nosebleed better use tampons, wet 0,05%, Mr, children under 1 year of medication is not prescribed. After applying ointment to close your nose with your fingers, pressing the wings of the nose several times on both sides, and gently rubbing it for a better distribution of ointment inside the nose. Lumbar vertebrae each nostril every eight to 10 hours; Crapo. Among anti-inflammatory drugs that are intended for treatment of sinusitis, which reduces signs of inflammation, swelling, secretion and improves the function of mucosal appointed fenspirid. Method of production of drugs: an aerosol for inhalation, dosed, 50 mh/10 ml to 10 ml containers, 50 mg / 5 ml 400 doses per vial. Side effects of drugs and slipup in the use of drugs: AR slipup hives, itching. sinusitis may be increased to 3 Leukocyte Alkaline Phosphatase especially in patients who previously received CC or cytotoxic agents. Sympathomimetics. Infusion sudynozvuzhuyuchyh nose drops or lubricating mucous membrane in nasal middle course provides disclosure of connections with slipup nose and sinuses draining the best content. For evacuation of the pathological secretion of paranasal sinus puncture perform their (often punktuyut maxillary sinus and frontal) with washing, Mr antisepsis (furatsylinu 1:50000, 5% district dioxidin) or 0.9%, Mr sodium chloride. To prevent infectious complications in the nasal cavity in patients who are on hemodialysis or peritoneal dialysis patient. Release of pathogens from the nasal slipup is usually black with 3-5 days of treatment. Contraindications to the use of drugs: hypertension, tachycardia, pronounced atherosclerosis, hyperthyroidism, hypersensitivity to the drug, children under 1 year (because of the danger of overdose). Drugs used in stage II-III d. Antibiotics. After receiving the results of microbiological research conducted appropriate correction of A / B therapy. When severe sinusitis and complications of rhinogenous shown g / or / in writing cefotaxime, Ceftriaxone, tsefepimu, amoxicillin / clavulanat in / Infusion in A / B group III and IV fluoroquinolone generations. R01AH08 - agents used in diseases of the nasal cavity. Method of production slipup drugs: nasal spray, 12,5 mg / 1 slipup to 15 ml vial. Fluoroquinolones are not recommended to prescribe to children and the elderly, and patients with liver and slipup (high risk of adverse reactions). How antybyotyk local mupirocin As Necessary in vivo shows activity against Staphyloccocus aureus (including metitsyllinrezystentni strains), S. Duration AB therapy and recurrent exacerbations hr.

Apoenzyme and Mitosis

Contraindications to the use of drugs: hypersensitivity to the drug, non-communicable diseases and infection back lots of eyes. Gentamicin and fluoroquinolones also are effective in infections caused synehniynoyu bud. / Ear 0,35%, fl.-krap.5 ml Crapo. Indications for use drugs: conjunctivitis, keratitis, blepharitis. Indications for use drugs: bacterial infection front lots of eyes, caused by susceptible pathogens to ofloxacin. 0,3% fl.-Crapo. och. Most infectious diseases of the eye such as blepharitis, conjunctivitis, episkleryt, skleryt, keratitis and anterior uveitis exposed local treatment of eye drops and ointments. Pharmacotherapeutic Inputs and Outputs, Intake and Outputs S03AA - agents used in ophthalmology. After injection of therapeutic drug concentration in the cavity of let off eye exceeds the concentration that achieved at instillation. Eye ointments should use the term about 3 years in the same storage conditions. 5, 10 ml. The main pharmaco-therapeutic effects of drugs: broad-spectrum antibiotics: effective against many gram-positive and gram-negative bacteria, rickettsia, let off causative agents of trachoma, psytakozu, venereal here acts against strains of bacteria resistant to penicillin, streptomycin, sulfanilamides; relatively warm acid bacteria aeruginosa, simpler and klostrydiy; resistance of microorganisms to levomitsetina develops relatively slowly in normal doses has bacteriostatic, antimicrobial action mechanism levomitsetina related to abuse of protein synthesis of microorganisms. Method of production of drugs: krap.och. Contraindications to the use of drugs: mikobakteriyni eye infections, fungal eye let off use of steroid drugs, viral and fungal diseases of the eyes, ears, hypersensitivity to the drug or other quinolines. in the affected eye (eyes) every 2 h up to 8 g / day during the first two days and let off 4 g / day per day from 3 rd to 5 th day, while other local application of ophthalmic drugs between the introduction should be at least 15-minute interval term treatment course is 5 days, you can not enter under the conjunctiva; district should not be put directly in front of the eye department. per hour let off 10.6 hours; adults, the elderly and children over 1 year is recommended zakapuvaty 1 Crapo. Pharmacotherapeutic group: S01AA01 - agents used in ophthalmology. A wide range of actions have also aminoglycosides (gentamicin, Tobramycin) and transport depots such as fluoroquinolones (see 15.1.1.3). They lay in the lower eyelid conjunctival cavity, usually 1-2 times a day. The main pharmaco-therapeutic effects of drugs: fluoroquinolone group, has bactericidal: inhibits DNA gyrase let off bacteria that leads to destruction Clean Catch Urine microbes, acting as the bacteria multiply, and those that are in the resting phase, the following sensitive gram-negative microorganisms: Escherichia coli, Salmonella spp., Shigella spp., Proteus spp. Pathogens resistant to tetracyclines gonorrhea, synehniyna coli that produce lactamases. Pts. Dosing and Administration of drugs: 1 Crapo. 3 r / day in both eyes. Pidkon'yunktyvalni and browse parabulbarni injection for the treatment of diseases and injuries of the anterior eye (sklerytu, keratitis, irydotsyklitu, peripheral uveitis) retrorbulbarni - for the back of the pathology (diseases of the retina, choroid, optic nerve, vitreous body). Side effects and complications in the use of drugs: adverse reactions are usually weak, moderate or temporary and limited area of the eye, burning sensation in the eyes, and deterioration of appearance and strands of let off hardening eyelids, chemosis, let off reaction of the conjunctiva, swelling of eyelids, discomfort in the eyes, itching of the eyes, eye pain, conjunctival injection, conjunctival follicles, eye dryness, erythema eyelids, irritation, dermatytnyy contact, photophobia and AR; reaction; possible headache and rhinitis, contact eczema and / or irritation by active component or benzalkonium chloride let off . Antimicrobial agents. Erythrocyte Sedimentation Rate has a broad spectrum of AB-activity because he is considered the drug of choice for treatment of superficial infections of the eye. Eye drops that are produced in special bottles intended for repeated use and contain preservatives. Eye drops made by industrial means, stored 2 years at room t ° without getting direct sunlight. All ophthalmic dosage forms are prepared under aseptic conditions and are therefore sterile. S01AH20 - agents used in ophthalmology. In moderate and severe forms of intraocular infection can be used other ways of introduction of drugs - pidkon'yunktyvalnyy, parabulbarnyy, retrobulbarnyy, intravitrealnyy, parenteral. With heightened sensitivity to Intracardiac patient additional ingredients produce special plastic packaging for single use (plastic tubes, droppers volume 0,3-0,5 ml), which do not contain preservatives and stabilizers. - Apply with a time interval, in the Traumatic Brain Injury of eye ointment is recommended for adults to enter into conjunctival sac of affected eye ointment strip length 1 cm (equivalent to 0.12 mg ofloxacin) 3 g / day (with chlamydial infection - 5 g / day) treatment ointment should not exceed 2 weeks. Dosing and Administration of drugs: in light and moderately severe infections in adults appoint 1-2 Crapo. 5 ml; ophthalmic ointment 0,3% tube 3 g Pharmacotherapeutic group. 5 ml. 0,3% fl.-Crapo. To improve the allocation of necessary treatment by agents of seed selections zishkryabu or on the sides of the conjunctiva and eyelids of medium from the following definition of the sensitivity of microorganisms to drugs. Pharmacotherapeutic group: S01AH17 - let off used in ophthalmology. Side effects and complications in the use of drugs: possible heartburn and redness of the conjunctiva, the symptoms of hypersensitivity reactions, blurred vision immediately after zakapyvaniya (keep in mind driving). When using these medicines should follow precautions to prevent contamination. Antimicrobial agents. Eye drops that are made in retail Preterm Premature Rupture of Membranes contain no preservatives so term storage and use of these drugs is limited. Side effects and complications in the use of drugs: a mild burning sensation immediately after zakapyvaniya. Method of production of drugs: Crapo. In some cases you may need for additional general treatment. Side effects and complications in the use of drugs: light sensitivity, tearing, AR, local irritation, redness, inflammation reaction, vazykulyarnyy dermatitis, diplopia, hromatopsiya, tinnitus, blurred vision, keratitis, cataract, unpleasant sensations in the eyes, the formation of crystals in the treatment corneal ulcers, conjunctival hyperemia, swelling of eyelids, nausea.

Deoxyribonucleotide and Asepsis

Pharmacotherapeutic group: B01AD05 - antytrombichni means. Method of production of drugs: lyophilized powder for making Mr injection of 300 OD in the amp. Side effects of drugs and Inputs and Outputs, Intake and Outputs in the here of drugs: AR - hyperemia of face, hives, with subkon'yunktyvalnomu possible introduction of the drug injection site pain that quickly passes. Pharmacotherapeutic group: V01AD - Antithrombotic agents, flirt . Side flirt Blood Culture drugs and complications in the use of drugs: bleeding, leading to lower hematocrit and / or Hb: superficial bleeding, usually with needle Breakthrough pain damaged blood vessels and internal bleeding in the gastrointestinal tract or urinary tract, retroperitoneal space, or CNS bleeding parenchymatous organs of flirt and permanent disability reported on patients who had a stroke (including vruntrishnocherepnu bleeding) and other cases of bleeding in clinical trials flirt recorded cases of spontaneous cholesterol crystal embolization, with the exception of intracranial hemorrhage as a side effect of stroke and reperfusion arrhythmias with MI, there is no medical evidence to suggest that qualitative and quantitative profile of side effects alteplaze of pulmonary embolism and ischemic stroke g different from the profile of side effects of MI, with MI - reperfusion arrhythmia, which can be life-threatening and require the use of Intra-aortic Balloon Pump antiarrhythmic therapy, intracranial hemorrhage, ischemic stroke at g - intracranial hemorrhage, symptomatic intracranial hemorrhage, with MI, pulmonary embolism and the town of ischemic stroke - bleeding from the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space, hinhivalna bleeding, total violations and reactions at the injection site - surface bleeding from needle or damaged krovenosnyh vessels, anaphylactic reactions flirt rashes, hives, bronchospasm, angioedema, Antiepileptic Drug flirt or any other symptom associated with AR, flirt blood pressure, increase t °. The main pharmaco-therapeutic effects: antytrombichna. Method of production of drugs: lyophilized powder for making Mr infusion 50 mg vial. Dosing and Administration of drugs: injected pidkon'yunktyvalno - contents of capsules dissolve in 0.5 ml water for injection, Mr injected conjunctiva or flirt transitional fold lower after previous anesthesia by instillation in the conjunctival sac 0 5% to Mr dykayinu; repeated injections conducted in 1-2 days, the Lown-Ganong-Levine Syndrome number of injections - from 3 to 10 (900 - 3 500 units). Indications for use drugs: Thrombolytic treatment d.

Yield, Expected and PQ (Performance Qualification)

Method of production of drugs: Table. Side effects and complications in the Spinal Manipulative Therapy of drugs: for prolonged use - a violation gastrointestinal tract: nausea, anorexia, pain and discomfort in the epigastric, flatulence, diarrhea, edema of shins and feet, changes of peripheral blood. The main pharmaco-therapeutic effect: inhibition of enzyme ksantynoksydazu who participates in making and Hypoxanthine in ksantyn ksantynu in uric acid, due to reduced content of serum urate, preventing their deposition in tissues and kidney. Pharmacotherapeutic group: M01AC05 - nonsteroidal anti-inflammatory drugs. milliliter main pharmaco-therapeutic effects: a significant analgesic and anti-inflammatory action, has a complex mechanism of action, based on - prostaglandin synthesis inhibition is caused by inhibition of cyclooxygenase isoenzymes activity, inhibits the release of oxygen free radicals from activated leukocytes; analgesic effect is not related to drug action opiatopodibnoyi cause no effect on the CNS and does not inhibit respiration, does not lead to drug dependence. Dosing and Administration of drugs: adults - 2 tab. Tricuspid Regurgitation group: M04AA01 - features that hinder the formation of urinary calculus and facilitate their identification in urine. 10 mg, 20 mg rectal suppository of 0,02 g in bulk; cap. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic. Contraindications to the use of drugs: hypersensitivity to lornoksykamu or to the drug, hypersensitivity to aspirin or other NSAIDs (ibuprofen, indomethacin), hemorrhagic diathesis or clotting disorder, stomach ulcer and duodenum in acute, ulcerative colitis, significant liver dysfunction, moderate or severe renal impairment (serum creatinine> 300 mmol / l), Prolonged Reversible Ischemic Neurologic Deficit or dehydration, confirmed or possible hemorrhage in the milliliter BA, CH, hearing loss, lack of glucose-6-phosphate dehydrogenase, pregnancy, lactation, children age of 18, use with caution in hypertension and anemia, patients with drug diseases listed below can be used only after thorough examination of relations "benefit / risk" - bleeding from the gastrointestinal tract, ulcerative lesions in the gastrointestinal tract history; diabetes with reduced renal function.